Pereiti prie turinio
Žmogaus safeninės venos endotelio ląstelės (HSVEC)
Audinys
Saphenous vein
Liga
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastazių vieta
Not applicable (normal, non-tumorigenic primary cell)
Sinonimai
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Dokumentai

Žmogaus safeninės venos endotelio ląstelės (HSVEC)

Primary cell · Prekės numeris 300699

Venous endothelium for bypass graft research

€1,220.00neįskaitant mokesčių ir pristatymo išlaidų

Pritaikymas / Rekomendacijos

Pagaminta pagal užsakymą
1

01Bendra informacija

Aprašymas

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Audinys
Saphenous vein
Liga
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastazių vieta
Not applicable (normal, non-tumorigenic primary cell)
Paraiškos
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Sinonimai
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Donoras

Donoro amžius
Lot-specific (see CoA)
Etninė priklausomybė
Lot-specific (see CoA)

03Klasifikacija

Organizmas
Žmogus
Seksas
Priklausantis nuo partijos
Augimo savybės
Prisijungęs
GMO statusas
Be GMO
Išsami informacija apie GMO statusą
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Biologinio saugumo lygis
1

04Charakteristikos

Morfologija
Cobblestone (endothelial)
Ląstelių tipas
Primary endothelial cells
Tumorogeninis
No
Laikas, per kurį skaičius padvigubėja
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Laikymas ir auginimas

Maitinamoji terpė
Endothelial Cell Growth Medium
Inkubacijos aplinka

37°C, 5% CO2, saturated humidity.

Maisto papildai
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Disociacijos reagentas
Subculture reagents as recommended on the certificate of analysis
Kolbos danga
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Subkultūrinis auginimas

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Skaidymo santykis
1 to 3
Sėjos tankis
More than 6,000 cells/cm²
Skysčių atnaujinimas
24 hours after seeding, then every 48 to 72 hours
Atkūrimas po atšilimo

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Atšildymas ir auginimas
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Kokybės kontrolė ir kriokonservavimas

Sterilumas

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Šaldymo terpė
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Laikymo sąlygos

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Pristatymo sąlygos

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Išraiška ir jautrumas

Paviršiaus antigenai
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Išreikšti receptoriai
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Identifikatoriai

Nuoroda
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
NCBI mokesčių identifikavimo kodas
9606
Cellosaurus
Not assigned